Consolidated Balance Sheets (Parenthetical) - USD ($) $ in Millions	Dec. 31, 2024	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Fixed maturity available-for-sale securities, at fair value
Amortized Cost	$ 97,415	$ 97,433
Allowance for credit losses	46	19	$ 22	$ 19
Mortgage loans on real estate, net of allowance for credit losses
Fair value	$ 232	$ 288
Stockholders’ Equity
Preferred stock, authorized (in shares)	10,000,000	10,000,000
Preferred stock, issued (in shares)	40,000	40,000
Preferred stock, outstanding (in shares)	40,000	40,000
Common stock, authorized (in shares)	800,000,000	800,000,000
Common stock, issued (in shares)	170,380,646	169,666,137
Common stock, outstanding (in shares)	170,380,646	169,666,137	169,220,511	177,193,515
Series C Preferred Stock
Stockholders’ Equity
Preferred stock, authorized (in shares)	20,000	20,000
Preferred stock, issued (in shares)	20,000	20,000
Preferred stock, outstanding (in shares)	20,000	20,000
Series D Preferred Stock
Stockholders’ Equity
Preferred stock, authorized (in shares)		20,000
Preferred stock, issued (in shares)	20,000	20,000
Preferred stock, outstanding (in shares)	20,000